SCHEDULE: Citadel and Kenneth Griffin Disclose Significant Stake in Nano Labs Ltd
Beneficial Ownership Disclosure
Citadel entities and Kenneth Griffin have disclosed beneficial ownership of 9.5% of Nano Labs Ltd's Class A ordinary shares, totaling 2,085,799 shares.
Summary
- Citadel Advisors LLC, Citadel Advisors Holdings LP, and Citadel GP LLC collectively beneficially own 2,038,777 Class A ordinary shares of Nano Labs Ltd, representing 9.3% of the class.
- Citadel Securities LLC, Citadel Securities Group LP, and Citadel Securities GP LLC collectively beneficially own 47,022 Class A ordinary shares, representing 0.2% of the class.
- Kenneth Griffin, through his controlling interest in the Citadel entities, beneficially owns an aggregate of 2,085,799 Class A ordinary shares, representing 9.5% of the class.
- The percentages are based on 22,012,924 total Class A ordinary shares outstanding, which includes 20,712,924 shares outstanding as of June 27, 2025 (per the issuer's prospectus) and 1,300,000 shares issuable upon conversion of certain warrants held by affiliates of the reporting persons.
- The reported holdings of the reporting persons are as of the opening of the market on July 7, 2025.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
NA
Industry Context
This filing indicates a significant passive investment by a major institutional investor, Citadel, and its founder, Kenneth Griffin, in Nano Labs Ltd. Such disclosures are common for large investment firms that cross beneficial ownership thresholds, reflecting their portfolio positions rather than direct operational involvement or strategic partnership.
Stakeholder Impact
- Shareholders: The disclosure of a significant stake by a prominent investment firm like Citadel may be viewed positively by existing shareholders, potentially signaling confidence in the company, though the filing explicitly states the shares were not acquired for the purpose of changing or influencing control.
Key Dates
| Date | Description |
|---|---|
| 06/27/2025 | Date of event which required the filing of this statement, and the date as of which 20,712,924 shares were outstanding according to the issuer's prospectus. |
| 07/07/2025 | Date of filing this Schedule 13G statement and the date as of which the reporting persons' holdings were calculated. |
| 10/13/2023 | Date of previous power of attorney filing by Citadel Advisors LLC for Allakos Inc., incorporated by reference. |
Keywords
Nano Labs Ltd, Citadel Advisors LLC, Kenneth Griffin, Beneficial Ownership, Schedule 13G, Class A ordinary shares, SEC filing, Investment, Equity Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.